Thus, the neuroprotective benefits of grafted NSCs or derived neurons largely seem to be achieved through the secretion of neurotrophin or neurotransmitters, which might, in turn, contribute to the repair of brain damage and correction of cognitive deficits in AD patients. This evidence concerns the gene BDNF and Alzheimer disease.